Skip to content
OpenCapital
Get started

ADMA Biologics ADMA ADMA Bio Manufacturing — Research And Development Expense

Other segment segments

Plasma Collection Centers
$0—

Similar metrics at other companies

Adaptive Biotechnologies logo
ADPTMrd Business — Research And Development Expense
$9.23M+0.7%
Dyne Therapeutics, Inc. logo
DYNDYNE-251DM1 — Research And Development Expense
$37.75M+79.0%
Becton, Dickinson and Company logo
BDXBioPharma Systems — Research and development expense
$17M-5.6%
AnaptysBio, Inc. logo
ANABBiopharma Company — Research And Development Expense Excluding Acquired In Process Cost
$34.9M-8.4%
Tyra Biosciences, Inc. logo
TYRAACH — Research And Development Expense
$4.31M+20.1%
Becton, Dickinson and Company logo
BDXMedical — Research and development expense
$130.75M+17.0%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's adma bio manufacturing — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's ADMA bio manufacturing — research and development expense?
ADMA Biologics (ADMA) reported ADMA bio manufacturing — research and development expense of $2.6M in Q1 2026.
How has ADMA Biologics's ADMA bio manufacturing — research and development expense changed year-over-year?
ADMA Biologics's ADMA bio manufacturing — research and development expense increased by 214.4% year-over-year, from $826K to $2.6M.
What is the long-term trend for ADMA Biologics's ADMA bio manufacturing — research and development expense?
Over 3 years (2022 to 2025), ADMA Biologics's ADMA bio manufacturing — research and development expense has grown at a 9.6% compound annual growth rate (CAGR), from $3.61M to $4.76M.
What does ADMA bio manufacturing — research and development expense mean?
Captures the costs associated with the discovery, development, and clinical testing of new specialty biologics within the manufacturing segment. This investment reflects the company's commitment to long-term innovation and future product pipeline expansion.